U.S. Markets open in 3 hrs 11 mins

Shares of Sage Therapeutics up on Zulresso approval, but analysts expect a slow rollout

Sarah Toy
Shares of Sage Therapeutics up on Zulresso approval, but analysts expect a slow rollout

Shares of Sage Therapeutics Inc. rose 3% Wednesday morning after the company’s announcement Tuesday evening that the Food and Drug Administration had approved its drug for the treatment of postpartum depression.